Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1-(2,3-dihydro-1,4-benzodioxin-5-yl)piperazine
2. Du 28853
3. Du-28853
4. Eltoprazine Hydrochloride
5. Piperazine, 1-(2,3-dihydro-1,4-benzodioxin-5-yl)-, Hydrochloride
1. 98224-03-4
2. 98206-09-8
3. 1-(2,3-dihydrobenzo[b][1,4]dioxin-5-yl)piperazine
4. 1-(2,3-dihydro-benzo[1,4]dioxin-5-yl)-piperazine
5. Eltoprazine [inn]
6. 1-(1,4-benzodioxan-5-yl)piperazine
7. 1-(2,3-dihydro-1,4-benzodioxin-5-yl)piperazine
8. Chembl282614
9. 510m006ko6
10. 1-(2,3-dihydrobenzo[1,4]dioxin-5-yl)piperazine
11. Eltoprazinum [latin]
12. Eltoprazina [spanish]
13. Ncgc00159533-01
14. Eltoprazina
15. Eltoprazinum
16. Eltoprazine [mi]
17. Eltoprazine [mart.]
18. Schembl177715
19. Piperazine, 1-(2,3-dihydro-1,4-benzodioxin-5-yl)-
20. Zinc1347
21. N-(benzodioxan-5-yl)piperazine
22. Dtxsid5048425
23. Unii-510m006ko6
24. Bcp19313
25. 1-(1,4-benzodioxan-5-yl)piperazin
26. Am1234
27. Bdbm50035057
28. Mfcd00868056
29. Pdsp1_000561
30. Pdsp2_000559
31. Akos016007669
32. 1-(1,4-benzodioxan-5-yl)-piperazine
33. Cs-3216
34. Db12883
35. Sb16767
36. Hy-16687
37. Ft-0667839
38. (2,3-dihydro[1,4]benzodioxin-5-yl)piperazine
39. H11026
40. 4-(2,3-dihydrobenzo[1,4]dioxin-5-yl)piperazine
41. A902315
42. L000982
43. 1-(2,3-dihydrobenzo[1,4]dioxin-5-yl)-piperazine
44. 4-(2,3-dihydrobenzo[1,4]dioxin-5-yl)-piperazine
45. Q5367896
46. 4-(2,3-dihydro-benzo[1,4]dioxin-5-yl)-piperazine
47. Brd-k86171477-003-01-9
48. (eltoprazine)1-(2,3-dihydro-benzo[1,4]dioxin-5-yl)-piperazine
49. 1-(2,3-dihydrobenzo[b][1,4]dioxin-5-yl)piperazine Hydrochloride Hydrochloride
Molecular Weight | 220.27 g/mol |
---|---|
Molecular Formula | C12H16N2O2 |
XLogP3 | 1.1 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 1 |
Exact Mass | 220.121177757 g/mol |
Monoisotopic Mass | 220.121177757 g/mol |
Topological Polar Surface Area | 33.7 Ų |
Heavy Atom Count | 16 |
Formal Charge | 0 |
Complexity | 231 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Serotonin Receptor Agonists
Endogenous compounds and drugs that bind to and activate SEROTONIN RECEPTORS. Many serotonin receptor agonists are used as ANTIDEPRESSANTS; ANXIOLYTICS; and in the treatment of MIGRAINE DISORDERS. (See all compounds classified as Serotonin Receptor Agonists.)
ABOUT THIS PAGE
A Eltoprazine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Eltoprazine, including repackagers and relabelers. The FDA regulates Eltoprazine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Eltoprazine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Eltoprazine supplier is an individual or a company that provides Eltoprazine active pharmaceutical ingredient (API) or Eltoprazine finished formulations upon request. The Eltoprazine suppliers may include Eltoprazine API manufacturers, exporters, distributors and traders.
Eltoprazine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Eltoprazine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Eltoprazine GMP manufacturer or Eltoprazine GMP API supplier for your needs.
A Eltoprazine CoA (Certificate of Analysis) is a formal document that attests to Eltoprazine's compliance with Eltoprazine specifications and serves as a tool for batch-level quality control.
Eltoprazine CoA mostly includes findings from lab analyses of a specific batch. For each Eltoprazine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Eltoprazine may be tested according to a variety of international standards, such as European Pharmacopoeia (Eltoprazine EP), Eltoprazine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Eltoprazine USP).
LOOKING FOR A SUPPLIER?